Tecentriq 840 MG/14 ML vial 14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJG5K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,034
Award facts
- Contract value 100% obligated
- $28,033.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $28,033.98 to AmerisourceBergen Drug Corp for the supply of Tecentriq (atezolizumab) 840 mg/14 mL vials on January 6, 2026, with an ultimate completion date of January 28, 2026. This firm fixed-price, non-competitive award was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order represents a task order issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. Tecentriq is an oncology medication commonly used in cancer treatment protocols, reflecting the contract vehicle's broad coverage of pharmaceutical products across multiple therapeutic domains to support Department of Defense and other federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FJG5K?
SPE2DR26FJG5K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FJG5K worth?
The government has obligated $28,034 on SPE2DR26FJG5K.
Is contract SPE2DR26FJG5K an order under another contract?
Yes. SPE2DR26FJG5K is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJG5K competed?
The extent of competition for SPE2DR26FJG5K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award